Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial
Michail Ignatiadis, Andrew Bailey, Heather McArthur, Sarra El-abed, Evandro de Azambuja, Otto Metzger, Stephen Y. Chui, Max Dieterich, Thomas Perretti, Esther Shearer-Kang, …
JAMA : the journal of the American Medical Association, Vol.333(13), pp.1150-1160
This randomized clinical trial investigates whether adding immune therapy to adjuvant chemotherapy for triple-negative breast cancer reduces recurrent disease.